Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of PF-08052667 as a Single Agent and in Combination Therapy in Participants 18 Years of Age and Older with Bladder Cancer
Study Type: Treatment
Phase: I
NCTID: NCT07206225
Principal Investigator:
John Taylor
Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer PARRC Trial
Study Type: Treatment
Phase: II
NCTID: NCT06770582
Principal Investigator:
Eugene Lee
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative with Evident Efficacy in Patients with Muscle Invasive Bladder Cancer
Study Type: Treatment
Phase: II
NCTID: NCT06493370
Principal Investigator:
John Taylor
METRICS Study: Metabolic Evaluation Through Resting Indirect Calorimetry in Bladder Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06721260
Principal Investigator:
Jill Hamilton-Reeves
Blue Light Cystoscopy with Cysview Patient Registry
Study Type: Other
Phase: N/A
NCTID: NCT02660645
Principal Investigator:
John Taylor
A Phase III Randomized Trial of Pembrolizumab in Combination with Sacituzumab Govitecan vs Standard of Care in Anti-PDL1-Resistant Advanced Urothelial Cancer
Study Type: Treatment
Phase: III
NCTID: NCT06524544
Principal Investigator:
Saqib Abbasi
MODERN: An Integrated Phase II/III and Phase III Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
Study Type: Treatment
Phase: II/III
NCTID: NCT05987241
Principal Investigator:
Saqib Abbasi
A Phase II Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants with FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer SURF302
Study Type: Treatment
Phase: II
NCTID: NCT06995677
Principal Investigator:
John Taylor
A Phase III Adaptive Radiation And Chemotherapy For Muscle Invasive Bladder Cancer Trial ARCHER
Study Type: Treatment
Phase: III
NCTID: NCT07097142
Principal Investigator:
Jay Shiao
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Study Type: Other
Phase: N/A
NCTID: NCT03413982
Principal Investigator:
John Taylor